Clinical trial
Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12…
NCT00204555 · University Hospital Tuebingen, Other · Completed
Key facts
| NCT number | NCT00204555 |
|---|---|
| Title | Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma |
| Official title | A Randomized Open Label Study to Evaluate the Safety and Efficacy if Imiquimod 5% Cream Applied 3 Times Per Week for 8 or 12 Weeks in the Treatment of Low Risk Nodular Basal Cell Carcinoma |
| Lead sponsor | University Hospital Tuebingen, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Carcinoma, Basal Cell |
| Intervention type | Drug |
| Interventions | Imiquimod |
| Enrollment | 100 |
| Start date | Jan 1, 2002 |
| Completion | Sep 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 1, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: